Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy
| Image |  |
|---|---|
| Description | scientific article published on 24 December 2012 |
| Author/s |
author: Robert K Hills |
| Publication date | December 24, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |